advertisement

Topcon

Congdon N 20

Showing records 1 to 20 | Display all abstracts from Congdon N

98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Sun Y
BMJ open 2022; 12: e053805
97999 Time trends, associations and global burden of intraocular foreign bodies
Jin G
British Journal of Ophthalmology 2022; 106: 435-439
98620 Facilitators and Barriers to Using Selective Laser Trabeculoplasty (SLT) as First-Line Treatment for Glaucoma: Physician and Patient Views Gathered during an Exploratory Descriptive Qualitative Study
Chen Y
Ophthalmic Epidemiology 2022; 0: 1-8
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Chen A
BMJ open 2022; 12: e053805
97999 Time trends, associations and global burden of intraocular foreign bodies
Zou M
British Journal of Ophthalmology 2022; 106: 435-439
98620 Facilitators and Barriers to Using Selective Laser Trabeculoplasty (SLT) as First-Line Treatment for Glaucoma: Physician and Patient Views Gathered during an Exploratory Descriptive Qualitative Study
Lohfeld L; Song D
Ophthalmic Epidemiology 2022; 0: 1-8
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Zou M
BMJ open 2022; 12: e053805
97999 Time trends, associations and global burden of intraocular foreign bodies
Zhang Y; Chen A
British Journal of Ophthalmology 2022; 106: 435-439
98620 Facilitators and Barriers to Using Selective Laser Trabeculoplasty (SLT) as First-Line Treatment for Glaucoma: Physician and Patient Views Gathered during an Exploratory Descriptive Qualitative Study
Pak C
Ophthalmic Epidemiology 2022; 0: 1-8
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Zhang Y; Jin L
BMJ open 2022; 12: e053805
98620 Facilitators and Barriers to Using Selective Laser Trabeculoplasty (SLT) as First-Line Treatment for Glaucoma: Physician and Patient Views Gathered during an Exploratory Descriptive Qualitative Study
Gong X
Ophthalmic Epidemiology 2022; 0: 1-8
97999 Time trends, associations and global burden of intraocular foreign bodies
Young CA; Li Y
British Journal of Ophthalmology 2022; 106: 435-439
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Li Y
BMJ open 2022; 12: e053805
98620 Facilitators and Barriers to Using Selective Laser Trabeculoplasty (SLT) as First-Line Treatment for Glaucoma: Physician and Patient Views Gathered during an Exploratory Descriptive Qualitative Study
Zhou W; Liang Y
Ophthalmic Epidemiology 2022; 0: 1-8
97999 Time trends, associations and global burden of intraocular foreign bodies
Jin L
British Journal of Ophthalmology 2022; 106: 435-439
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Zheng D; Jin G
BMJ open 2022; 12: e053805
98620 Facilitators and Barriers to Using Selective Laser Trabeculoplasty (SLT) as First-Line Treatment for Glaucoma: Physician and Patient Views Gathered during an Exploratory Descriptive Qualitative Study
Congdon N
Ophthalmic Epidemiology 2022; 0: 1-8
97999 Time trends, associations and global burden of intraocular foreign bodies
Congdon N
British Journal of Ophthalmology 2022; 106: 435-439
98459 Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017
Congdon N
BMJ open 2022; 12: e053805
97999 Time trends, associations and global burden of intraocular foreign bodies
Zheng D
British Journal of Ophthalmology 2022; 106: 435-439

Issue 22-4

Change Issue


advertisement

Oculus